PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
151.06%
Net income growth 1.25-1.5x AVGO's 106.45%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
6.47%
D&A growth well above AVGO's 2.56%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
84.48%
Deferred tax of 84.48% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-172.56%
Both reduce yoy usage, with AVGO at -132.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-667.43%
Both reduce yoy inventory, with AVGO at -107.14%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-114.58%
Both reduce yoy usage, with AVGO at -185.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
209.78%
Some yoy increase while AVGO is negative at -50.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-46.88%
Both yoy CFO lines are negative, with AVGO at -53.03%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-103.70%
Negative yoy CapEx while AVGO is 7.69%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
38.50%
Purchases growth of 38.50% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
21.13%
Liquidation growth of 21.13% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-107.77%
We reduce yoy other investing while AVGO is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
84.02%
Investing outflow well above AVGO's 33.33%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
180.86%
Issuance growth of 180.86% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.